DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Rapid Countermeasure Discovery against Francisella tularensis Based on a Metabolic Network Reconstruction

Abstract

In the future, we may be faced with the need to provide treatment for an emergent biological threat against which existing vaccines and drugs have limited efficacy or availability. To prepare for this eventuality, our objective was to use a metabolic network-based approach to rapidly identify potential drug targets and prospectively screen and validate novel small molecule antimicrobials. Our target organism was the fully virulent Francisella tularensis subspecies tularensis Schu S4 strain, a highly infectious intracellular pathogen that is the causative agent of tularemia and is classified as a category A biological agent by the Centers for Disease Control and Prevention. We proceeded with a staggered computational and experimental workflow that used a strain-specific metabolic network model, homology modeling and X-ray crystallography of protein targets, and ligand- and structure-based drug design. Selected compounds were subsequently filtered based on physiological-based pharmacokinetic modeling, and we selected a final set of 40 compounds for experimental validation of antimicrobial activity. We began screening these compounds in whole bacterial cell-based assays in biosafety level 3 facilities in the 20th week of the study and completed the screens within 12 weeks. Six compounds showed significant growth inhibition of F. tularensis, and we determined their respective minimummore » inhibitory concentrations and mammalian cell cytotoxicities. The most promising compound had a low molecular weight, was non-toxic, and abolished bacterial growth at 13 mM, with putative activity against pantetheine-phosphate adenylyltransferase, an enzyme involved in the biosynthesis of coenzyme A, encoded by gene coaD. The novel antimicrobial compounds identified in this study serve as starting points for lead optimization, animal testing, and drug development against tularemia. Our integrated in silico/in vitro approach had an overall 15% success rate in terms of active versus tested compounds over an elapsed time period of 32 weeks, from pathogen strain identification to selection and validation of novel antimicrobial compounds.« less

Authors:
 [1];  [1];  [1];  [2];  [3];  [3];  [3];  [3];  [4];  [4];  [4];  [4];  [5];  [6];  [6];  [6];  [7];  [2]
  1. US Army Medical Research and Material Command, Fort Detrick, MD (united States). Dept. of Defense Biotechnology High Performance Computing Software Applications Inst., Telemedicine and Advanced Technology Research Center
  2. U.S. Army Medical Research and Materiel Command, Fort Detrick, MD (United States). Telemedicine and Advanced Technology Research Center. Dept. of Defense Biotechnology High Performance Computing Software Applications Inst.
  3. Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States). Pathogen Bioinformatics
  4. New York Structural Biology Center, New York, NY (United States)
  5. General Electric Company, Niskayuna, NY (United States). GE Global Research. Diagnostics and Biomedical Technologies. Computational Biology and Biostatistics Lab.
  6. U.S. Army Medical Research Inst. for Infectious Diseases, Fort Detrick, MD (United States). Bacteriology Division
  7. Mount Sinai School of Medicine, New York, NY (United States)
Publication Date:
Research Org.:
Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division
OSTI Identifier:
1627608
Grant/Contract Number:  
AC52-07NA27344
Resource Type:
Accepted Manuscript
Journal Name:
PLoS ONE
Additional Journal Information:
Journal Volume: 8; Journal Issue: 5; Journal ID: ISSN 1932-6203
Publisher:
Public Library of Science
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; Enzyme metabolism; Francisella tularensis; drug metabolism; crystal structure; drug discovery; enzymes; protein structure; metabolic networks

Citation Formats

Chaudhury, Sidhartha, Abdulhameed, Mohamed Diwan M., Singh, Narender, Tawa, Gregory J., D’haeseleer, Patrik M., Zemla, Adam T., Navid, Ali, Zhou, Carol E., Franklin, Matthew C., Cheung, Jonah, Rudolph, Michael J., Love, James, Graf, John F., Rozak, David A., Dankmeyer, Jennifer L., Amemiya, Kei, Daefler, Simon, and Wallqvist, Anders. Rapid Countermeasure Discovery against Francisella tularensis Based on a Metabolic Network Reconstruction. United States: N. p., 2013. Web. doi:10.1371/journal.pone.0063369.
Chaudhury, Sidhartha, Abdulhameed, Mohamed Diwan M., Singh, Narender, Tawa, Gregory J., D’haeseleer, Patrik M., Zemla, Adam T., Navid, Ali, Zhou, Carol E., Franklin, Matthew C., Cheung, Jonah, Rudolph, Michael J., Love, James, Graf, John F., Rozak, David A., Dankmeyer, Jennifer L., Amemiya, Kei, Daefler, Simon, & Wallqvist, Anders. Rapid Countermeasure Discovery against Francisella tularensis Based on a Metabolic Network Reconstruction. United States. https://doi.org/10.1371/journal.pone.0063369
Chaudhury, Sidhartha, Abdulhameed, Mohamed Diwan M., Singh, Narender, Tawa, Gregory J., D’haeseleer, Patrik M., Zemla, Adam T., Navid, Ali, Zhou, Carol E., Franklin, Matthew C., Cheung, Jonah, Rudolph, Michael J., Love, James, Graf, John F., Rozak, David A., Dankmeyer, Jennifer L., Amemiya, Kei, Daefler, Simon, and Wallqvist, Anders. Tue . "Rapid Countermeasure Discovery against Francisella tularensis Based on a Metabolic Network Reconstruction". United States. https://doi.org/10.1371/journal.pone.0063369. https://www.osti.gov/servlets/purl/1627608.
@article{osti_1627608,
title = {Rapid Countermeasure Discovery against Francisella tularensis Based on a Metabolic Network Reconstruction},
author = {Chaudhury, Sidhartha and Abdulhameed, Mohamed Diwan M. and Singh, Narender and Tawa, Gregory J. and D’haeseleer, Patrik M. and Zemla, Adam T. and Navid, Ali and Zhou, Carol E. and Franklin, Matthew C. and Cheung, Jonah and Rudolph, Michael J. and Love, James and Graf, John F. and Rozak, David A. and Dankmeyer, Jennifer L. and Amemiya, Kei and Daefler, Simon and Wallqvist, Anders},
abstractNote = {In the future, we may be faced with the need to provide treatment for an emergent biological threat against which existing vaccines and drugs have limited efficacy or availability. To prepare for this eventuality, our objective was to use a metabolic network-based approach to rapidly identify potential drug targets and prospectively screen and validate novel small molecule antimicrobials. Our target organism was the fully virulent Francisella tularensis subspecies tularensis Schu S4 strain, a highly infectious intracellular pathogen that is the causative agent of tularemia and is classified as a category A biological agent by the Centers for Disease Control and Prevention. We proceeded with a staggered computational and experimental workflow that used a strain-specific metabolic network model, homology modeling and X-ray crystallography of protein targets, and ligand- and structure-based drug design. Selected compounds were subsequently filtered based on physiological-based pharmacokinetic modeling, and we selected a final set of 40 compounds for experimental validation of antimicrobial activity. We began screening these compounds in whole bacterial cell-based assays in biosafety level 3 facilities in the 20th week of the study and completed the screens within 12 weeks. Six compounds showed significant growth inhibition of F. tularensis, and we determined their respective minimum inhibitory concentrations and mammalian cell cytotoxicities. The most promising compound had a low molecular weight, was non-toxic, and abolished bacterial growth at 13 mM, with putative activity against pantetheine-phosphate adenylyltransferase, an enzyme involved in the biosynthesis of coenzyme A, encoded by gene coaD. The novel antimicrobial compounds identified in this study serve as starting points for lead optimization, animal testing, and drug development against tularemia. Our integrated in silico/in vitro approach had an overall 15% success rate in terms of active versus tested compounds over an elapsed time period of 32 weeks, from pathogen strain identification to selection and validation of novel antimicrobial compounds.},
doi = {10.1371/journal.pone.0063369},
journal = {PLoS ONE},
number = 5,
volume = 8,
place = {United States},
year = {Tue May 21 00:00:00 EDT 2013},
month = {Tue May 21 00:00:00 EDT 2013}
}

Works referenced in this record:

A Francisella tularensis Live Vaccine Strain That Improves Stimulation of Antigen-Presenting Cells Does Not Enhance Vaccine Efficacy
journal, February 2012


Drugs for bad bugs: confronting the challenges of antibacterial discovery
journal, December 2006

  • Payne, David J.; Gwynn, Michael N.; Holmes, David J.
  • Nature Reviews Drug Discovery, Vol. 6, Issue 1
  • DOI: 10.1038/nrd2201

Constraint-based analysis of metabolic capacity of Salmonella typhimurium during host-pathogen interaction
journal, January 2009

  • Raghunathan, Anu; Reed, Jennifer; Shin, Sookil
  • BMC Systems Biology, Vol. 3, Issue 1
  • DOI: 10.1186/1752-0509-3-38

Integrative genome‐scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery
journal, January 2011

  • Kim, Hyun Uk; Kim, Soo Young; Jeong, Haeyoung
  • Molecular Systems Biology, Vol. 7, Issue 1
  • DOI: 10.1038/msb.2010.115

Reconstruction of biochemical networks in microorganisms
journal, December 2008

  • Feist, Adam M.; Herrgård, Markus J.; Thiele, Ines
  • Nature Reviews Microbiology, Vol. 7, Issue 2
  • DOI: 10.1038/nrmicro1949

Development of Functional and Molecular Correlates of Vaccine-Induced Protection for a Model Intracellular Pathogen, F. tularensis LVS
journal, January 2012


Cheminformatics analysis and learning in a data pipelining environment
journal, August 2006

  • Hassan, Moises; Brown, Robert D.; Varma-O’Brien, Shikha
  • Molecular Diversity, Vol. 10, Issue 3
  • DOI: 10.1007/s11030-006-9041-5

Metabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical disease
journal, January 2012

  • Chavali, Arvind K.; Blazier, Anna S.; Tlaxca, Jose L.
  • BMC Systems Biology, Vol. 6, Issue 1
  • DOI: 10.1186/1752-0509-6-27

Chorismate Synthase: An Attractive Target For Drug Development Against Orphan Diseases
journal, March 2007


Evaluation of Live Tularemia Vaccine Prepared in a Chemically Defined Medium
journal, January 1965


The RCSB Protein Data Bank: redesigned web site and web services
journal, October 2010

  • Rose, P. W.; Beran, B.; Bi, C.
  • Nucleic Acids Research, Vol. 39, Issue Database
  • DOI: 10.1093/nar/gkq1021

Genome Sequence of E. coli O104:H4 Leads to Rapid Development of a Targeted Antimicrobial Agent against This Emerging Pathogen
journal, March 2012


Systems biology, metabolic modelling and metabolomics in drug discovery and development
journal, December 2006


Virtual screening to identify lead inhibitors for bacterial NAD synthetase (NADs)
journal, April 2009

  • Moro, Whitney Beysselance; Yang, Zhengrong; Kane, Tasha A.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 19, Issue 7
  • DOI: 10.1016/j.bmcl.2009.02.034

DEG 5.0, a database of essential genes in both prokaryotes and eukaryotes
journal, January 2009

  • Zhang, R.; Lin, Y.
  • Nucleic Acids Research, Vol. 37, Issue Database
  • DOI: 10.1093/nar/gkn858

Targeting multiple targets in Pseudomonas aeruginosa PAO1 using flux balance analysis of a reconstructed genome-scale metabolic network
journal, March 2010

  • Perumal, Deepak; Samal, Areejit; Sakharkar, Kishore R.
  • Journal of Drug Targeting, Vol. 19, Issue 1
  • DOI: 10.3109/10611861003649753

Comparing metabolic network models based on genomic and automatically inferred enzyme information from Plasmodium and its human host to define drug targets in silico
journal, June 2011


Modeling Phenotypic Metabolic Adaptations of Mycobacterium tuberculosis H37Rv under Hypoxia
journal, September 2012


BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems
journal, December 2011

  • Graf, John F.; Scholz, Bernhard J.; Zavodszky, Maria I.
  • Journal of Pharmacokinetics and Pharmacodynamics, Vol. 39, Issue 1
  • DOI: 10.1007/s10928-011-9229-x

DrugBank: a comprehensive resource for in silico drug discovery and exploration
journal, January 2006


A Protein-Free Medium for Primary Isolation of the Gonococcus and Meningococcus
journal, October 1941


A Series of 2(Z)-2-Benzylidene-6,7-dihydroxybenzofuran-3[2H]-ones as Inhibitors of Chorismate Synthase.
journal, June 2003

  • Thomas, Michael G.; Lawson, Chris; Allanson, Nigel M.
  • ChemInform, Vol. 34, Issue 22
  • DOI: 10.1002/chin.200322106

Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds
journal, April 2008

  • Obach, R. Scott; Lombardo, Franco; Waters, Nigel J.
  • Drug Metabolism and Disposition, Vol. 36, Issue 7
  • DOI: 10.1124/dmd.108.020479

A metabolic network approach for the identification and prioritization of antimicrobial drug targets
journal, March 2012

  • Chavali, Arvind K.; D’Auria, Kevin M.; Hewlett, Erik L.
  • Trends in Microbiology, Vol. 20, Issue 3
  • DOI: 10.1016/j.tim.2011.12.004

Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy
journal, March 2004

  • Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.
  • Journal of Medicinal Chemistry, Vol. 47, Issue 7
  • DOI: 10.1021/jm0306430

BRENDA, the enzyme information system in 2011
journal, November 2010

  • Scheer, M.; Grote, A.; Chang, A.
  • Nucleic Acids Research, Vol. 39, Issue Database
  • DOI: 10.1093/nar/gkq1089

Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox
journal, March 2007

  • Becker, Scott A.; Feist, Adam M.; Mo, Monica L.
  • Nature Protocols, Vol. 2, Issue 3
  • DOI: 10.1038/nprot.2007.99

Clustal W and Clustal X version 2.0
journal, September 2007


Molecular shape and electrostatics in the encoding of relevant chemical information
journal, September 2005

  • Nicholls, Anthony; Grant, J. Andrew
  • Journal of Computer-Aided Molecular Design, Vol. 19, Issue 9-10
  • DOI: 10.1007/s10822-005-9019-x

Tularaemia: bioterrorism defence renews interest in Francisella tularensis
journal, December 2004

  • Oyston, Petra C. F.; Sjöstedt, Anders; Titball, Richard W.
  • Nature Reviews Microbiology, Vol. 2, Issue 12
  • DOI: 10.1038/nrmicro1045

Extra Precision Glide:  Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand Complexes
journal, October 2006

  • Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.
  • Journal of Medicinal Chemistry, Vol. 49, Issue 21
  • DOI: 10.1021/jm051256o

A series of 2(Z)-2-Benzylidene-6,7-dihydroxybenzofuran-3[2H]-ones as inhibitors of chorismate synthase
journal, February 2003

  • Thomas, Michael G.; Lawson, Chris; Allanson, Nigel M.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 13, Issue 3
  • DOI: 10.1016/S0960-894X(02)00957-5

DrugBank and its relevance to pharmacogenomics
journal, August 2008


PubChem: a public information system for analyzing bioactivities of small molecules
journal, June 2009

  • Wang, Y.; Xiao, J.; Suzek, T. O.
  • Nucleic Acids Research, Vol. 37, Issue Web Server
  • DOI: 10.1093/nar/gkp456

Tularemia as a Biological Weapon: Medical and Public Health Management
journal, June 2001


Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool
journal, April 1997

  • Bower, Michael J.; Cohen, Fred E.; Dunbrack, Roland L.
  • Journal of Molecular Biology, Vol. 267, Issue 5
  • DOI: 10.1006/jmbi.1997.0926

Francisella tularensis: Taxonomy, Genetics, and Immunopathogenesis of a Potential Agent of Biowarfare
journal, October 2006


Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool
journal, April 1997

  • Bower, Michael J.; Cohen, Fred E.; Dunbrack, Roland L.
  • Journal of Molecular Biology, Vol. 267, Issue 5
  • DOI: 10.1006/jmbi.1997.0926

Identification of Potential Leptospira Phosphoheptose Isomerase Inhibitors Through Virtual High-Throughput Screening
journal, December 2010

  • Umamaheswari, Amineni; Pradhan, Dibyabhaba; Hemanthkumar, Marisetty
  • Genomics, Proteomics & Bioinformatics, Vol. 8, Issue 4
  • DOI: 10.1016/s1672-0229(10)60026-5

Assessing the performance of OMEGA with respect to retrieving bioactive conformations
journal, March 2003

  • Boström, Jonas; Greenwood, Jeremy R.; Gottfries, Johan
  • Journal of Molecular Graphics and Modelling, Vol. 21, Issue 5
  • DOI: 10.1016/S1093-3263(02)00204-8

The ENZYME database in 2000
journal, January 2000


Extra Precision Glide:  Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand Complexes
journal, October 2006

  • Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.
  • Journal of Medicinal Chemistry, Vol. 49, Issue 21
  • DOI: 10.1021/jm051256o

Basic local alignment search tool
journal, October 1990

  • Altschul, Stephen F.; Gish, Warren; Miller, Webb
  • Journal of Molecular Biology, Vol. 215, Issue 3, p. 403-410
  • DOI: 10.1016/S0022-2836(05)80360-2

AS2TS system for protein structure modeling and analysis
journal, July 2005

  • Zemla, A.; Zhou, C. E.; Slezak, T.
  • Nucleic Acids Research, Vol. 33, Issue Web Server
  • DOI: 10.1093/nar/gki457

A Genome-Scale Metabolic Reconstruction of Mycoplasma genitalium, iPS189
journal, February 2009

  • Suthers, Patrick F.; Dasika, Madhukar S.; Kumar, Vinay Satish
  • PLoS Computational Biology, Vol. 5, Issue 2
  • DOI: 10.1371/journal.pcbi.1000285

Pathway of Diphosphopyridine Nucleotide Biosynthesis in Escherichia coli
journal, May 1961


Blueprint for antimicrobial hit discovery targeting metabolic networks
journal, January 2010

  • Shen, Y.; Liu, J.; Estiu, G.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 3
  • DOI: 10.1073/pnas.0909181107

Comparing metabolic network models based on genomic and automatically inferred enzyme information from Plasmodium and its human host to define drug targets in silico
journal, January 2011


Virtual screening to identify lead inhibitors for bacterial NAD synthetase (NADs)
journal, April 2009

  • Moro, Whitney Beysselance; Yang, Zhengrong; Kane, Tasha A.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 19, Issue 7
  • DOI: 10.1016/j.bmcl.2009.02.034

Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7
journal, June 2008

  • Langer, Gerrit; Cohen, Serge X.; Lamzin, Victor S.
  • Nature Protocols, Vol. 3, Issue 7
  • DOI: 10.1038/nprot.2008.91

Development and analysis of an in vivo-compatible metabolic network of Mycobacterium tuberculosis
journal, January 2010


A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis
journal, January 2009

  • Fang, Xin; Wallqvist, Anders; Reifman, Jaques
  • BMC Systems Biology, Vol. 3, Issue 1
  • DOI: 10.1186/1752-0509-3-92

Protein secondary structure prediction based on position-specific scoring matrices 1 1Edited by G. Von Heijne
journal, September 1999


A Francisella tularensis Live Vaccine Strain That Improves Stimulation of Antigen-Presenting Cells Does Not Enhance Vaccine Efficacy
journal, February 2012


Metabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical disease
journal, January 2012

  • Chavali, Arvind K.; Blazier, Anna S.; Tlaxca, Jose L.
  • BMC Systems Biology, Vol. 6, Issue 1
  • DOI: 10.1186/1752-0509-6-27

Versatile and open software for comparing large genomes
journal, January 2004

  • Kurtz, Stefan; Phillippy, Adam; Delcher, Arthur L.
  • Genome Biology, Vol. 5, Issue 2, R12
  • DOI: 10.1186/gb-2004-5-2-r12

DEG 5.0, a database of essential genes in both prokaryotes and eukaryotes
journal, January 2009

  • Zhang, R.; Lin, Y.
  • Nucleic Acids Research, Vol. 37, Issue Database
  • DOI: 10.1093/nar/gkn858

Chorismate Synthase: An Attractive Target For Drug Development Against Orphan Diseases
journal, March 2007


Constraint-based analysis of metabolic capacity of Salmonella typhimurium during host-pathogen interaction
journal, January 2009

  • Raghunathan, Anu; Reed, Jennifer; Shin, Sookil
  • BMC Systems Biology, Vol. 3, Issue 1
  • DOI: 10.1186/1752-0509-3-38

ChEMBL: a large-scale bioactivity database for drug discovery
journal, September 2011

  • Gaulton, A.; Bellis, L. J.; Bento, A. P.
  • Nucleic Acids Research, Vol. 40, Issue D1
  • DOI: 10.1093/nar/gkr777

Clustal W and Clustal X version 2.0
journal, September 2007


Systems biology, metabolic modelling and metabolomics in drug discovery and development
journal, December 2006


Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy
journal, March 2004

  • Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.
  • Journal of Medicinal Chemistry, Vol. 47, Issue 7
  • DOI: 10.1021/jm0306430

A metabolic network approach for the identification and prioritization of antimicrobial drug targets
journal, March 2012

  • Chavali, Arvind K.; D’Auria, Kevin M.; Hewlett, Erik L.
  • Trends in Microbiology, Vol. 20, Issue 3
  • DOI: 10.1016/j.tim.2011.12.004

A comprehensive transposon mutant library of Francisella novicida , a bioweapon surrogate
journal, January 2007

  • Gallagher, Larry A.; Ramage, Elizabeth; Jacobs, Michael A.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 3
  • DOI: 10.1073/pnas.0606713104

Cheminformatics analysis and learning in a data pipelining environment
journal, August 2006

  • Hassan, Moises; Brown, Robert D.; Varma-O’Brien, Shikha
  • Molecular Diversity, Vol. 10, Issue 3
  • DOI: 10.1007/s11030-006-9041-5

Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening
journal, March 2004

  • Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.
  • Journal of Medicinal Chemistry, Vol. 47, Issue 7
  • DOI: 10.1021/jm030644s

Drugs for bad bugs: confronting the challenges of antibacterial discovery
journal, December 2006

  • Payne, David J.; Gwynn, Michael N.; Holmes, David J.
  • Nature Reviews Drug Discovery, Vol. 6, Issue 1
  • DOI: 10.1038/nrd2201

DrugBank: a knowledgebase for drugs, drug actions and drug targets
journal, November 2007

  • Wishart, David S.; Knox, Craig; Guo, An Chi
  • Nucleic Acids Research, Vol. 36, Issue suppl_1
  • DOI: 10.1093/nar/gkm958

AS2TS system for protein structure modeling and analysis
journal, July 2005

  • Zemla, A.; Zhou, C. E.; Slezak, T.
  • Nucleic Acids Research, Vol. 33, Issue Web Server
  • DOI: 10.1093/nar/gki457

Targeting multiple targets in Pseudomonas aeruginosa PAO1 using flux balance analysis of a reconstructed genome-scale metabolic network
journal, March 2010

  • Perumal, Deepak; Samal, Areejit; Sakharkar, Kishore R.
  • Journal of Drug Targeting, Vol. 19, Issue 1
  • DOI: 10.3109/10611861003649753

Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds
journal, April 2008

  • Obach, R. Scott; Lombardo, Franco; Waters, Nigel J.
  • Drug Metabolism and Disposition, Vol. 36, Issue 7
  • DOI: 10.1124/dmd.108.020479

LGA: a method for finding 3D similarities in protein structures
journal, July 2003


Evaluation of Live Tularemia Vaccine Prepared in a Chemically Defined Medium
journal, March 1965


Metabolic network modeling and simulation for drug targeting and discovery
journal, November 2011

  • Kim, Hyun Uk; Sohn, Seung Bum; Lee, Sang Yup
  • Biotechnology Journal, Vol. 7, Issue 3
  • DOI: 10.1002/biot.201100159

The Universal Protein Resource (UniProt)
journal, December 2004

  • Bairoch, A.
  • Nucleic Acids Research, Vol. 33, Issue Database issue
  • DOI: 10.1093/nar/gki070

Development and analysis of an in vivo-compatible metabolic network of Mycobacterium tuberculosis
journal, January 2010


Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7
journal, June 2008

  • Langer, Gerrit; Cohen, Serge X.; Lamzin, Victor S.
  • Nature Protocols, Vol. 3, Issue 7
  • DOI: 10.1038/nprot.2008.91

Reconstruction of biochemical networks in microorganisms
journal, December 2008

  • Feist, Adam M.; Herrgård, Markus J.; Thiele, Ines
  • Nature Reviews Microbiology, Vol. 7, Issue 2
  • DOI: 10.1038/nrmicro1949

Crystal structure of quinolinic acid phosphoribosyltransferase from Mycobacterium tuberculosis: a potential TB drug target
journal, December 1998


Purification and Characterization of Phosphopantetheine Adenylyltransferase from Escherichia coli
journal, September 1999

  • Geerlof, Arie; Lewendon, Ann; Shaw, William V.
  • Journal of Biological Chemistry, Vol. 274, Issue 38
  • DOI: 10.1074/jbc.274.38.27105

Genome Sequence of E. coli O104:H4 Leads to Rapid Development of a Targeted Antimicrobial Agent against This Emerging Pathogen
journal, March 2012


Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases
journal, June 1989


Tularemia as a Biological Weapon: Medical and Public Health Management
journal, June 2001


Structure and Function of Sedoheptulose-7-phosphate Isomerase, a Critical Enzyme for Lipopolysaccharide Biosynthesis and a Target for Antibiotic Adjuvants
journal, February 2008

  • Taylor, Patricia L.; Blakely, Kim M.; de Leon, Gladys P.
  • Journal of Biological Chemistry, Vol. 283, Issue 5
  • DOI: 10.1074/jbc.m706163200

A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis
journal, January 2009

  • Fang, Xin; Wallqvist, Anders; Reifman, Jaques
  • BMC Systems Biology, Vol. 3, Issue 1
  • DOI: 10.1186/1752-0509-3-92

Alignment of whole genomes
journal, January 1999

  • Delcher, A. L.; Kasif, S.; Fleischmann, R. D.
  • Nucleic Acids Research, Vol. 27, Issue 11
  • DOI: 10.1093/nar/27.11.2369

DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
journal, November 2010

  • Knox, C.; Law, V.; Jewison, T.
  • Nucleic Acids Research, Vol. 39, Issue Database
  • DOI: 10.1093/nar/gkq1126

The ENZYME database in 2000
journal, January 2000


Alignment of whole genomes
journal, January 1999

  • Delcher, A. L.; Kasif, S.; Fleischmann, R. D.
  • Nucleic Acids Research, Vol. 27, Issue 11
  • DOI: 10.1093/nar/27.11.2369

DrugBank and its relevance to pharmacogenomics
journal, August 2008


PubChem: a public information system for analyzing bioactivities of small molecules
journal, June 2009

  • Wang, Y.; Xiao, J.; Suzek, T. O.
  • Nucleic Acids Research, Vol. 37, Issue Web Server
  • DOI: 10.1093/nar/gkp456

DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
journal, November 2010

  • Knox, C.; Law, V.; Jewison, T.
  • Nucleic Acids Research, Vol. 39, Issue Database
  • DOI: 10.1093/nar/gkq1126

Tularaemia: bioterrorism defence renews interest in Francisella tularensis
journal, December 2004

  • Oyston, Petra C. F.; Sjöstedt, Anders; Titball, Richard W.
  • Nature Reviews Microbiology, Vol. 2, Issue 12
  • DOI: 10.1038/nrmicro1045

BRENDA, the enzyme information system in 2011
journal, November 2010

  • Scheer, M.; Grote, A.; Chang, A.
  • Nucleic Acids Research, Vol. 39, Issue Database
  • DOI: 10.1093/nar/gkq1089

Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox
journal, March 2007

  • Becker, Scott A.; Feist, Adam M.; Mo, Monica L.
  • Nature Protocols, Vol. 2, Issue 3
  • DOI: 10.1038/nprot.2007.99

Blueprint for antimicrobial hit discovery targeting metabolic networks
journal, January 2010

  • Shen, Y.; Liu, J.; Estiu, G.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 3
  • DOI: 10.1073/pnas.0909181107

DrugBank: a knowledgebase for drugs, drug actions and drug targets
journal, November 2007

  • Wishart, David S.; Knox, Craig; Guo, An Chi
  • Nucleic Acids Research, Vol. 36, Issue suppl_1
  • DOI: 10.1093/nar/gkm958

A Genome-Scale Metabolic Reconstruction of Mycoplasma genitalium, iPS189
journal, February 2009

  • Suthers, Patrick F.; Dasika, Madhukar S.; Kumar, Vinay Satish
  • PLoS Computational Biology, Vol. 5, Issue 2
  • DOI: 10.1371/journal.pcbi.1000285

Modeling synergistic drug inhibition of Mycobacterium tuberculosis growth in murine macrophages
journal, January 2011

  • Fang, Xin; Wallqvist, Anders; Reifman, Jaques
  • Molecular BioSystems, Vol. 7, Issue 9
  • DOI: 10.1039/c1mb05106g

DrugBank: a comprehensive resource for in silico drug discovery and exploration
journal, January 2006


Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
journal, December 1983


LGA: a method for finding 3D similarities in protein structures
journal, July 2003


A comprehensive transposon mutant library of Francisella novicida , a bioweapon surrogate
journal, January 2007

  • Gallagher, Larry A.; Ramage, Elizabeth; Jacobs, Michael A.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 3
  • DOI: 10.1073/pnas.0606713104

The RCSB Protein Data Bank: redesigned web site and web services
journal, October 2010

  • Rose, P. W.; Beran, B.; Bi, C.
  • Nucleic Acids Research, Vol. 39, Issue Database
  • DOI: 10.1093/nar/gkq1021

The Universal Protein Resource (UniProt)
journal, December 2004

  • Bairoch, A.
  • Nucleic Acids Research, Vol. 33, Issue Database issue
  • DOI: 10.1093/nar/gki070

Development of Functional and Molecular Correlates of Vaccine-Induced Protection for a Model Intracellular Pathogen, F. tularensis LVS
journal, January 2012


Reproducing the conformations of protein-bound ligands: A critical evaluation of several popular conformational searching tools
journal, December 2001

  • Boström, Jonas
  • Journal of Computer-Aided Molecular Design, Vol. 15, Issue 12, p. 1137-1152
  • DOI: 10.1023/A:1015930826903

Integrative genome‐scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery
journal, January 2011

  • Kim, Hyun Uk; Kim, Soo Young; Jeong, Haeyoung
  • Molecular Systems Biology, Vol. 7, Issue 1
  • DOI: 10.1038/msb.2010.115

Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening
journal, March 2004

  • Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.
  • Journal of Medicinal Chemistry, Vol. 47, Issue 7
  • DOI: 10.1021/jm030644s

Mechanistic systems modeling to guide drug discovery and development
journal, February 2013


Works referencing / citing this record:

Accelerating the Drug Development Pipeline with Genome-Scale Metabolic Network Reconstructions
book, January 2017